U.S. market Closed. Opens in 4 hours 8 minutes

WST | West Pharmaceutical Services, Inc. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for WST we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is very wealthy, Growth is very good and Health is very strong.

Valuation (43%)

Company Industry
P/E Ratio (TTM) 40.19 50.98
PEG Ratio (TTM) -5.42 8.78
P/S Ratio (TTM) 7.29 11.80
P/B Ratio (TTM) 8.19 6.40
P/FCF Ratio (TTM) 58.71 317.68
Price to 5YR AVG Earnings Ratio 44.18 109.24
Price to 5YR AVG FCF Ratio 60.82 84.60

Profitability (80%)

Company Industry
ROA (TTM) 15.04% 6.88%
ROE (TTM) 19.08% 12.81%
Net Profit Margin (TTM) 18.25% 4.19%
ROIC 5YR AVG 30.58% 11.09%

Growth (72%)

4QTR AVG 3YR AVG 5YR AVG
EPS -7.31% 50.03% 28.00%
Revenue -1.74% 18.57% 11.97%
Net Income -7.59% 50.41% 28.21%
Cash Flow 7.23% 26.50% 22.15%

Health (74%)

Company Industry
Current Ratio (TTM) 2.34 3.36
Quick Ratio (TTM) 1.68 2.55
D/E Ratio (TTM) 0.09 0.40
Interest Coverage (TTM) 82.19 27.77
Piotroski F-Score 6 6
Altman Z-Score 16.99 22.14
LTL to 5YR AVG FCF 0.46 4.42
Shares Outstanding Growth 5YR AVG 0.11% 2.66%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙